(Allergan plc)

	AGN latest price $161.8900 (-0.46%) ($161.8600 - $163.1250) on Tue. Jul. 23, 2019.
	Trend Analysis and Forecast
Average Daily Percentage Swing	3.71% (three month average)
RSI	22
Latest Price	$161.8900(-0.46%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -0.3% a day on average for past five trading days.
Weekly Trend	AGN declines -1.6% a week on average for past two weeks.
Market Behavior	Broad based rally for large cap. Broad based rally for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IVW(82%)    IWF(82%)    VT(82%)    VUG(82%)    XLV(82%)
Factors Impacting AGN price	AGN will decline at least -1.855% in a week (0% probabilities).   VXX(-69%)    VIXM(-61%)    TLT(-43%)    IFRA(-40%)    BWX(-13%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1.855% (StdDev 3.71%)
Hourly BBV	0 ()
Intraday Trend	-0.6%

Resistance Level	$165.3
5 Day Moving Average	$162.44(-0.34%)
10 Day Moving Average	$164(-1.29%)
20 Day Moving Average	$165.3(-2.06%)
To recent high	-4.6%
To recent low	39.9%
Market Cap	$53.375b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed